Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
AXSM
AXSM
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AXSM News
Axsome Therapeutics Stock Analysis Ahead of Earnings
2d ago
Yahoo Finance
Axsome Therapeutics Stock Soars 75% Amid Strong Growth
Feb 05 2026
Fool
Analyzing Future Growth Potential of Axsome Therapeutics
Feb 03 2026
Fool
CommVault and Axsome Options Trading Activity Surges
Jan 27 2026
NASDAQ.COM
Piper Sandler Raises Axsome Therapeutics (AXSM) Price Target to $223, Optimistic on Alzheimer’s Drug Potential
Jan 23 2026
Yahoo Finance
Axsome Therapeutics (AXSM) Projects $638.5M Revenue in 2025, $507.1M from Auvelity
Jan 17 2026
stocktwits
Axsome Therapeutics (AXSM) Projects $638.5M Revenue for 2025, 66% Growth
Jan 12 2026
NASDAQ.COM
Axsome Therapeutics (AXSM) Reports Q4 2025 Net Revenue of ~$196M, 65% Y/Y Growth
Jan 12 2026
seekingalpha
Axsome and Exelixis: New Investment Opportunities in Biotech
Jan 08 2026
Fool
Axsome and Exelixis Show Significant Revenue Growth in Biotech Sector
Jan 08 2026
NASDAQ.COM
Axsome Therapeutics Director Mark E Saad Sells 37,577 Shares for $6 Each
Jan 05 2026
Yahoo Finance
Health Care Stocks Decline as NYSE Health Care Index Drops 0.5%
Dec 31 2025
Yahoo Finance
Axsome Therapeutics Receives Buy Rating with Price Target of $178.74
Dec 31 2025
Yahoo Finance
Axsome Therapeutics Receives FDA Priority Review for AXS-05, Shares Surge Nearly 20%
Dec 31 2025
Fool
Axsome Receives FDA Priority Review for AXS-05 Drug
Dec 31 2025
NASDAQ.COM
FuelCell Energy Files for $200 Million Stock Offering, Shares Drop 8.9%
Dec 31 2025
Benzinga
Show More News
